~~<i id='12A4A2AA2B'><strike id='12A4A2AA2B'><tt id='12A4A2AA2B'><pre id='12A4A2AA2B'></pre></tt></strike></i>~~

Home» explore» entertainment

entertainment

author：leisure time 2025-09-27 09:21:42 Page View：579

Monica Bertagnolli -- health policy coverage from STAT — NIH Director Monica Bertagnolli Kevin Dietsch/Getty Images

WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally funded research — and now, in a major recent move, said he’ll trigger government “march-in” on patents for drugs that run afoul of that goal.

“It’s a simple principle. You shouldn’t pay the highest price in the world for drugs that your tax dollars have already helped create,” Biden said last month as he touted the move at the National Institutes of Health.

But the new NIH director, locked in the center of this debate, isn’t taking any big steps yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Surgeons perform first xenotransplant using CRISPR'd pig kidney
Next article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban

knowledge

Medicare details structure of new drug price negotiation program

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

ScientistFengZhang,right,isinterviewedbyreporterMeganMolteniatSTAT'sBreakthroughSummitEast.STATWhent

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

ASCO eve: Let’s set the table for this year's meeting

ThisistheonlineeditionofAdam’sBiotechScorecard,asubscriber-onlynewsletter.STAT+subscriberscansignuph